Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-3,714
Closed -$208K 300
2020
Q4
$208K Sell
3,714
-368
-9% -$19.6K 0.02% 231
2020
Q3
$226K Buy
+4,082
New +$212K 0.02% 197
2019
Q3
Sell
-6,417
Closed -$276K 200
2019
Q2
$276K Sell
6,417
-44
-0.7% -$1.82K 0.03% 160
2019
Q1
$279K Buy
+6,461
New +$260K 0.03% 159

Other funds holding QGEN

Keel Point's QGEN Position: Q1 2021 in Review

Keel Point sold out of Qiagen (QGEN) in Q1 2021, closing a stake of 3,714 shares — an estimated $208K sold.

Keel Point first reported a position in QGEN in Q1 2019 and held it in 4 quarters. The position peaked at $279K in Q1 2019. 274 funds tracked by Wall St. Rank hold QGEN as of Q1 2021.

  • Keel Point reported no remaining Qiagen position as of Q1 2021 after selling out during the quarter.
  • Keel Point sold 3,714 Qiagen shares in Q1 2021, an estimated $208K.
  • Keel Point first reported a position in Qiagen in Q1 2019 and held it in 4 quarters.
  • Keel Point's Qiagen position peaked at $279K in Q1 2019.
  • 274 funds tracked by Wall St. Rank held Qiagen as of Q1 2021.

Based on Keel Point's 13F filing for Q1 2021, filed 17 May 2021.